B Weigelt1, A J Bosma, L J van 't Veer. 1. Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Abstract
PURPOSE: The purpose of this study was to examine breast tumors and normal breast tissues for the expression of the glycoprotein lacritin. The mRNA and protein expression of lacritin has been reported to be restricted to the lacrimal gland. METHODS: We investigated 37 human primary invasive breast tumors, seven breast cancer cell lines and 16 normal breast tissues by quantitative real-time PCR for lacritin expression. RESULTS: We detected lacritin transcripts in 51% (19/37) of the primary invasive breast tumors, in 71% (5/7) of the breast cancer cell lines, and also in 56% (9/16) of the normal breast tissues. No lacritin mRNA was detectable in peripheral blood of healthy individuals. CONCLUSIONS: Here we show by quantitative real-time PCR that lacritin is expressed in human breast tumors, breast cancer cell lines, and normal breast. The previously reported restricted expression pattern of lacritin is therefore incorrect. Lacritin transcripts were not detected in peripheral blood which makes lacritin a potential candidate as a breast cancer marker gene.
PURPOSE: The purpose of this study was to examine breast tumors and normal breast tissues for the expression of the glycoprotein lacritin. The mRNA and protein expression of lacritin has been reported to be restricted to the lacrimal gland. METHODS: We investigated 37 human primary invasive breast tumors, seven breast cancer cell lines and 16 normal breast tissues by quantitative real-time PCR for lacritin expression. RESULTS: We detected lacritin transcripts in 51% (19/37) of the primary invasive breast tumors, in 71% (5/7) of the breast cancer cell lines, and also in 56% (9/16) of the normal breast tissues. No lacritin mRNA was detectable in peripheral blood of healthy individuals. CONCLUSIONS: Here we show by quantitative real-time PCR that lacritin is expressed in humanbreast tumors, breast cancer cell lines, and normal breast. The previously reported restricted expression pattern of lacritin is therefore incorrect. Lacritin transcripts were not detected in peripheral blood which makes lacritin a potential candidate as a breast cancer marker gene.
Authors: S Sanghi; R Kumar; A Lumsden; D Dickinson; V Klepeis; V Trinkaus-Randall; H F Frierson; G W Laurie Journal: J Mol Biol Date: 2001-06-29 Impact factor: 5.469
Authors: H Caron; B van Schaik ; M van der Mee ; F Baas; G Riggins; P van Sluis ; M C Hermus; R van Asperen ; K Boon; P A Voûte; S Heisterkamp; A van Kampen ; R Versteeg Journal: Science Date: 2001-02-16 Impact factor: 47.728
Authors: Astrid J Bosma; Britta Weigelt; A Caro Lambrechts; Onno J H M Verhagen; Roelof Pruntel; Augustinus A M Hart; Sjoerd Rodenhuis; Laura J van 't Veer Journal: Clin Cancer Res Date: 2002-06 Impact factor: 12.531
Authors: Aldona A Karaczyn; Robert Y S Cheng; Gregory S Buzard; James Hartley; Dominic Esposito; Kazimierz S Kasprzak Journal: Ann Clin Lab Sci Date: 2009 Impact factor: 1.256
Authors: Yinghui Zhang; Ningning Wang; Ronald W Raab; Robert L McKown; Jacob A Irwin; Inchan Kwon; Toin H van Kuppevelt; Gordon W Laurie Journal: J Biol Chem Date: 2013-03-15 Impact factor: 5.157
Authors: Jiahu Wang; Ningning Wang; Jinling Xie; Staci C Walton; Robert L McKown; Ronald W Raab; Peisong Ma; Shannon L Beck; George L Coffman; Isa M Hussaini; Gordon W Laurie Journal: J Cell Biol Date: 2006-08-21 Impact factor: 10.539
Authors: Jasna Bancovik; Dayson F Moreira; Daniel Carrasco; Jun Yao; Dale Porter; Ricardo Moura; Anamaria Camargo; Cibely C Fontes-Oliveira; Miguel G Malpartida; Silvia Carambula; Edouard Vannier; Bryan E Strauss; Alda Wakamatsu; Venancio Af Alves; Angela F Logullo; Fernando A Soares; Kornelia Polyak; José E Belizário Journal: BMC Cancer Date: 2015-02-19 Impact factor: 4.430
Authors: Peter Arne Gerber; Peter Hevezi; Bettina Alexandra Buhren; Cynthia Martinez; Holger Schrumpf; Marcia Gasis; Susanne Grether-Beck; Jean Krutmann; Bernhard Homey; Albert Zlotnik Journal: PLoS One Date: 2013-06-20 Impact factor: 3.240
Authors: Xuan Huang; Gina Reye; Konstantin I Momot; Tony Blick; Thomas Lloyd; Wayne D Tilley; Theresa E Hickey; Cameron E Snell; Rachel K Okolicsanyi; Larisa M Haupt; Vito Ferro; Erik W Thompson; Honor J Hugo Journal: Front Cell Dev Biol Date: 2020-07-14